We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy


Can We Repair the Brain in Parkinson's Disease?


Can We Repair the Brain in Parkinson's Disease?

Who's speaking at this Webinar?

Roger Barker
Professor of Clinical Neuroscience/Honorary Consultant Neurologist, University of Cambridge

The pathophysiology of Parkinson's disease

Parkinson's Disease (PD) is a common neurodegenerative disorder of the brain that is characterised pathologically by the loss of nigral dopaminergic neurons. Whilst motor features of the disease respond well to current dopaminergic treatments, side effects such as dyskinesia and neuropsychiatric problems are common over time.

Parkinson's disease treatments

These problems could, in theory, be avoided through targeted delivery of dopamine to the dorsal striatum as is possible with neuronal replacement approaches or growth factor (GDNF) delivery. These strategies have been tried over the last 20-30 years and shown long-term clinical benefit in some patients. But efficacy is inconsistent, and these new therapies often have their own side effects.

In this webinar, the University of Cambridge’s Professor Roger Barker will discuss the history, current status and potential of growth factor- and cell-based therapies for PD. 

Attend this webinar to hear:

  • The latest advances in cell-based treatments for PD
  • The potential of stem cell therapies for brain repair


Like what you just read? You can find similar content on the communities below.


To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free